Heterogeneity in background fitness acts as a suppressor of selection
نویسندگان
چکیده
منابع مشابه
Heterogeneity in background fitness acts as a suppressor of selection.
We introduce the concept of heterogeneity in background fitness to evolutionary dynamics in finite populations. Background fitness is specific to an individual but not linked to its strategy. It can be thought of as a property that is related to the physical or societal position of an individual, but is not dependent on the strategy that is adopted in the evolutionary process under consideratio...
متن کاملBEX1 acts as a tumor suppressor in acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease of the myeloid lineage. About 35% of AML patients carry an oncogenic FLT3 mutant making FLT3 an attractive target for treatment of AML. Major problems in the development of FLT3 inhibitors include lack of specificity, poor response and development of a resistant phenotype upon treatment. Further understanding of FLT3 signaling and discover...
متن کاملFOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma
Rhabdomyosarcoma (RMS), the most common pediatric soft-tissue sarcoma, has two major histological subtypes: embryonal RMS (ERMS), which has a favorable prognosis, and alveolar RMS (ARMS), which has a poor outcome. Although both forms of RMS express muscle cell-specific markers, only ARMS cells express PAX3-FOXO1a or PAX7-FOXO1a chimeric proteins. In mice, Pax3 and Pax7 play key roles in muscle ...
متن کاملThe H19 locus acts in vivo as a tumor suppressor.
The H19 locus belongs to a cluster of imprinted genes that is linked to the human Beckwith-Wiedemann syndrome. The expression of H19 and its closely associated IGF2 gene is frequently deregulated in some human tumors, such as Wilms' tumors. In these cases, biallelic IGF2 expression and lack of expression of H19 are associated with hypermethylation of the imprinting center of this locus. These o...
متن کاملGPER-1 acts as a tumor suppressor in ovarian cancer
BACKGROUND It is known that the new membrane-bound estrogen receptor GPER-1 acts suppressive in breast cancer cells and its expression decreases during disease progression. This study was conducted to evaluate the GPER-1 expression in ovarian cancer and its correlation with progression. Its function was tested in vitro in ovarian cancer cells. PATIENTS AND METHODS GPER-1 expression was analyz...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Theoretical Biology
سال: 2014
ISSN: 0022-5193
DOI: 10.1016/j.jtbi.2013.10.013